Last 12 months
Inside the activity.
0 purchase rows · 26 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 8 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 8 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 17, 2026 Filed Aug 19, 2026 21:06 UTC |
Miller William JohnDirector · CEO
|
SaleCommon Stock | 70,697 | $54.49 | $3,852,279.53 |
DisclosureSEC source: 0001497582-26-000021 · form4-08192026_090827.xml · nonDerivative · entry 3 Miller William John · CIK 0001497582 · Director · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 169,570 F3 · price: Reflects average weighted sale price. Actual sale prices ranged from $54.37 to $54.88 per share. The reporting person undertakes to provide, upon the request of the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 17, 2026 Filed Aug 19, 2026 21:06 UTC |
Miller William JohnDirector · CEO
|
SaleCommon Stock | 123,334 | $54.07 | $6,668,669.38 |
DisclosureSEC source: 0001497582-26-000021 · form4-08192026_090827.xml · nonDerivative · entry 2 Miller William John · CIK 0001497582 · Director · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 240,267 F2 · price: Reflects average weighted sale price. Actual sale prices ranged from $53.36 to $54.36 per share. The reporting person undertakes to provide, upon the request of the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 17, 2026 Filed Aug 19, 2026 21:06 UTC |
Miller William JohnDirector · CEO
|
SaleCommon Stock | 5,969 | $52.85 | $315,461.65 |
DisclosureSEC source: 0001497582-26-000021 · form4-08192026_090827.xml · nonDerivative · entry 1 Miller William John · CIK 0001497582 · Director · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 363,601 F1 · price: Reflects average weighted sale price. Actual sale prices ranged from $52.30 to $53.29 per share. The reporting person undertakes to provide, upon the request of the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 13, 2026 Filed Aug 14, 2026 20:30 UTC |
RAYMOND MARY JANEDirector
|
GiftCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001192758-26-000008 · form4-08142026_040821.xml · nonDerivative · entry 1 RAYMOND MARY JANE · CIK 0001192758 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,967 F1 · kind: This transaction involved a gift of securities by the reporting person to the Children's Hospital of Philadelphia. Read SEC document |
| August 10, 2026 Filed Aug 12, 2026 20:30 UTC |
KIERNAN JOHN PSVP & CHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 1,608 | $54.28 | $87,282.24 |
DisclosureSEC source: 0001251708-26-000012 · form4-08122026_040805.xml · nonDerivative · entry 5 KIERNAN JOHN P · CIK 0001251708 · SVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · By Family Trust Disclosed balance after: 68,802 Read SEC document |
| August 10, 2026 Filed Aug 12, 2026 20:30 UTC |
KIERNAN JOHN PSVP & CHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 800 | $53.44 | $42,752.00 |
DisclosureSEC source: 0001251708-26-000012 · form4-08122026_040805.xml · nonDerivative · entry 4 KIERNAN JOHN P · CIK 0001251708 · SVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · By Family Trust Disclosed balance after: 70,410 F4 · price: Reflects average weighted sale price. Actual sale prices ranged from $53.20 to $53.98 per share. The reporting person undertakes to provide, upon the request of the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 10, 2026 Filed Aug 12, 2026 20:30 UTC |
KIERNAN JOHN PSVP & CHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 2,100 | $52.50 | $110,250.00 |
DisclosureSEC source: 0001251708-26-000012 · form4-08122026_040805.xml · nonDerivative · entry 3 KIERNAN JOHN P · CIK 0001251708 · SVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · By Family Trust Disclosed balance after: 71,210 F3 · price: Reflects average weighted sale price. Actual sale prices ranged from $52.10 to $52.96 per share. The reporting person undertakes to provide, upon the request of the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 10, 2026 Filed Aug 12, 2026 20:30 UTC |
KIERNAN JOHN PSVP & CHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 10,236 | $51.29 | $525,004.44 |
DisclosureSEC source: 0001251708-26-000012 · form4-08122026_040805.xml · nonDerivative · entry 2 KIERNAN JOHN P · CIK 0001251708 · SVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · By Family Trust Disclosed balance after: 73,310 F2 · price: Reflects average weighted sale price. Actual sale prices ranged from $50.995 to $51.965 per share. The reporting person undertakes to provide, upon the request of the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 10, 2026 Filed Aug 12, 2026 20:30 UTC |
KIERNAN JOHN PSVP & CHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 20,256 | $50.42 | $1,021,307.52 |
DisclosureSEC source: 0001251708-26-000012 · form4-08122026_040805.xml · nonDerivative · entry 1 KIERNAN JOHN P · CIK 0001251708 · SVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · By Family Trust Disclosed balance after: 83,546 F1 · price: Reflects average weighted sale price. Actual sale prices ranged from $49.985 to $50.985 per share. The reporting person undertakes to provide, upon the request of the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 11, 2026 Filed Jun 12, 2026 20:30 UTC |
Wilkerson SusanSVP, GLOBAL SALES & SERVICE
|
SaleCommon Stock | 15,505.6 | $69.56 | $1,078,569.54 |
DisclosureSEC source: 0001809296-26-000012 · form4-06122026_040615.xml · nonDerivative · entry 1 Wilkerson Susan · CIK 0001809296 · SVP, GLOBAL SALES & SERVICE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,467.925 F1 · price: Reflects average weighted sale price. Actual sale prices ranged from $69.45 to $69.90 per share. The reporting person undertakes to provide, upon the request of the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 09, 2026 Filed Jun 10, 2026 20:30 UTC |
Devasahayam AdrianSVP - PRODUCT LINE DEVELOPMENT
|
SaleCommon Stock | 10,000 | $65.00 | $650,000.00 |
DisclosureSEC source: 0001811702-26-000012 · form4-06102026_040601.xml · nonDerivative · entry 1 Devasahayam Adrian · CIK 0001811702 · SVP - PRODUCT LINE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,115.208 Read SEC document |
| June 09, 2026 Filed Jun 10, 2026 20:25 UTC |
HUNTER GORDONDirector
|
SaleCommon Stock | 16,974 | $68.80 | $1,167,811.20 |
DisclosureSEC source: 0001186518-26-000022 · form4-06102026_040601.xml · nonDerivative · entry 1 HUNTER GORDON · CIK 0001186518 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,236 F1 · price: Reflects average weighted sale price. Actual sale prices ranged from $68.73 to 69.12 per share. The reporting person undertakes to provide, upon the request of the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 04, 2026 Filed Jun 8, 2026 21:30 UTC |
HUNTER GORDONDirector
|
SaleCommon Stock | 6,752 | $63.78 | $430,642.56 |
DisclosureSEC source: 0001186518-26-000019 · form4-06082026_050601.xml · nonDerivative · entry 1 HUNTER GORDON · CIK 0001186518 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,210 F1 · price: Reflects average weighted sale price. Actual sale prices ranged from $63.47 to 63.97 per share. The reporting person undertakes to provide, upon the request of the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 02, 2026 Filed Jun 2, 2026 20:30 UTC |
Miller William JohnDirector · CEO
|
SaleCommon Stock | 50,000 | $58.62 | $2,931,000.00 |
DisclosureSEC source: 0001497582-26-000017 · form4-06022026_040601.xml · nonDerivative · entry 1 Miller William John · CIK 0001497582 · Director · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 369,570 F1 · price: Reflects average weighted sale price. Actual sale prices ranged from $58.58 to $58.66 per share. The reporting person undertakes to provide, upon the request of the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 26, 2026 Filed May 27, 2026 20:35 UTC |
Wilkerson SusanSVP, GLOBAL SALES & SERVICE
|
SaleCommon Stock | 35,723 | $61.69 | $2,203,751.87 |
DisclosureSEC source: 0001809296-26-000010 · form4-05272026_040501.xml · nonDerivative · entry 1 Wilkerson Susan · CIK 0001809296 · SVP, GLOBAL SALES & SERVICE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,973.525 F1 · price: Reflects average weighted sale price. Actual sale prices ranged from $61.18 to $62.13 per share. The reporting person undertakes to provide, upon the request of the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 26, 2026 Filed May 27, 2026 20:30 UTC |
Devasahayam AdrianSVP - PRODUCT LINE DEVELOPMENT
|
SaleCommon Stock | 5,407 | $61.84 | $334,368.88 |
DisclosureSEC source: 0001811702-26-000010 · form4-05272026_040501.xml · nonDerivative · entry 1 Devasahayam Adrian · CIK 0001811702 · SVP - PRODUCT LINE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,115.208 F1 · price: Reflects average weighted sale price. Actual sale prices ranged from $61.82 to $61.87 per share. The reporting person undertakes to provide, upon the request of the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 26, 2026 Filed May 28, 2026 20:30 UTC |
HUNTER GORDONDirector
|
SaleCommon Stock | 17,714 | $61.61 | $1,091,359.54 |
DisclosureSEC source: 0001186518-26-000014 · form4-05282026_040520.xml · nonDerivative · entry 1 HUNTER GORDON · CIK 0001186518 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,962 F1 · price: Reflects average weighted sale price. Actual sale prices ranged from $61.57 to 61.83 per share. The reporting person undertakes to provide, upon the request of the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 14, 2026 Filed May 18, 2026 21:27 UTC |
DAMORE RICHARD ADirector
|
SaleCommon Stock | 43,701 | $60.71 | $2,653,087.71 |
DisclosureSEC source: 0001206641-26-000004 · form4-05182026_090524.xml · nonDerivative · entry 1 DAMORE RICHARD A · CIK 0001206641 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,594 F1 · price: Reflects average weighted sale price. Actual sale prices ranged from $60.42 to $61.15 per share. The reporting person undertakes to provide, upon the request of the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 12, 2026 Filed May 13, 2026 21:17 UTC |
HUNTER GORDONDirector
|
SaleCommon Stock | 29,532 | $59.41 | $1,754,496.12 |
DisclosureSEC source: 0001186518-26-000010 · form4-05132026_090542.xml · nonDerivative · entry 1 HUNTER GORDON · CIK 0001186518 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,676 F1 · price: Reflects average weighted sale price. Actual sale prices ranged from $59.10 to 59.69 per share. The reporting person undertakes to provide, upon the request of the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 11, 2026 Filed May 13, 2026 20:30 UTC |
St Dennis ThomasDirector
|
SaleCommon Stock | 1,400 | $61.93 | $86,702.00 |
DisclosureSEC source: 0001339595-26-000004 · form4-05132026_040505.xml · nonDerivative · entry 1 St Dennis Thomas · CIK 0001339595 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,697 Read SEC document |
| May 08, 2026 Filed May 11, 2026 20:45 UTC |
Chand SujeetDirector
|
GrantCommon Stock | 2,945 | $0.00 | $0.00 |
DisclosureSEC source: 0001388884-26-000002 · form4-05112026_040503.xml · nonDerivative · entry 1 Chand Sujeet · CIK 0001388884 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,079 F1 · shares: These shares were awarded as restricted stock pursuant to the Veeco Instruments Inc. 2019 Stock Incentive Plan in consideration of services as a director. These shares are subject to certain restrictions which shall lapse on the earlier to occur of: (i) the date immediately preceding the date of the Company's 2027 Annual Meeting of stockholders and (ii) the first anniversary of the award date. Read SEC document |
| May 08, 2026 Filed May 11, 2026 20:40 UTC |
St Dennis ThomasDirector
|
GrantCommon Stock | 2,945 | $0.00 | $0.00 |
DisclosureSEC source: 0001339595-26-000002 · form4-05112026_040503.xml · nonDerivative · entry 1 St Dennis Thomas · CIK 0001339595 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,097 F1 · shares: These shares were awarded as restricted stock pursuant to the Veeco Instruments Inc. 2019 Stock Incentive Plan in consideration of services as a director. These shares are subject to certain restrictions which shall lapse on the earlier to occur of: (i) the date immediately preceding the date of the Company's 2027 Annual Meeting of stockholders and (ii) the first anniversary of the award date. Read SEC document |
| May 08, 2026 Filed May 11, 2026 20:40 UTC |
Nicolaides LenaDirector
|
GrantCommon Stock | 2,945 | $0.00 | $0.00 |
DisclosureSEC source: 0001371144-26-000002 · form4-05112026_040501.xml · nonDerivative · entry 1 Nicolaides Lena · CIK 0001371144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,472 F1 · shares: These shares were awarded as restricted stock pursuant to the Veeco Instruments Inc. 2019 Stock Incentive Plan in consideration of services as a director. These shares are subject to certain restrictions which shall lapse on the earlier to occur of: (i) the date immediately preceding the date of the Company's 2027 Annual Meeting of stockholders and (ii) the first anniversary of the award date. Read SEC document |
| May 08, 2026 Filed May 11, 2026 20:35 UTC |
BAYLESS KATHLEEN ADirector
|
GrantCommon Stock | 2,945 | $0.00 | $0.00 |
DisclosureSEC source: 0001230569-26-000002 · form4-05112026_040503.xml · nonDerivative · entry 1 BAYLESS KATHLEEN A · CIK 0001230569 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,580 F1 · shares: These shares were awarded as restricted stock pursuant to the Veeco Instruments Inc. 2019 Stock Incentive Plan in consideration of services as a director. These shares are subject to certain restrictions which shall lapse on the earlier to occur of: (i) the date immediately preceding the date of the Company's 2027 Annual Meeting of stockholders and (ii) the first anniversary of the award date. Read SEC document |
| May 08, 2026 Filed May 11, 2026 20:35 UTC |
DAMORE RICHARD ADirector
|
GrantCommon Stock | 2,945 | $0.00 | $0.00 |
DisclosureSEC source: 0001206641-26-000002 · form4-05112026_040501.xml · nonDerivative · entry 1 DAMORE RICHARD A · CIK 0001206641 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,295 F1 · shares: These shares were awarded as restricted stock pursuant to the Veeco Instruments Inc. 2019 Stock Incentive Plan in consideration of services as a director. These shares are subject to certain restrictions which shall lapse on the earlier to occur of: (i) the date immediately preceding the date of the Company's 2027 Annual Meeting of stockholders and (ii) the first anniversary of the award date. Read SEC document |
| May 08, 2026 Filed May 11, 2026 20:30 UTC |
JACKSON KEITH DDirector
|
GrantCommon Stock | 2,945 | $0.00 | $0.00 |
DisclosureSEC source: 0001228890-26-000002 · form4-05112026_040527.xml · nonDerivative · entry 1 JACKSON KEITH D · CIK 0001228890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,154 F1 · shares: These shares were awarded as restricted stock pursuant to the Veeco Instruments Inc. 2019 Stock Incentive Plan in consideration of services as a director. These shares are subject to certain restrictions which shall lapse on the earlier to occur of: (i) the date immediately preceding the date of the Company's 2027 Annual Meeting of stockholders and (ii) the first anniversary of the award date. Read SEC document |
| May 08, 2026 Filed May 11, 2026 20:30 UTC |
HUNTER GORDONDirector
|
SaleCommon Stock | 7,746 | $58.76 | $455,154.96 |
DisclosureSEC source: 0001186518-26-000008 · form4-05112026_040525.xml · nonDerivative · entry 2 HUNTER GORDON · CIK 0001186518 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,208 F2 · price: Reflects average weighted purchase price. Actual purchase prices ranged from $58.53 to $58.86 per share. The reporting person undertakes to provide, upon the request of the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 08, 2026 Filed May 11, 2026 20:30 UTC |
HUNTER GORDONDirector
|
GrantCommon Stock | 2,945 | $0.00 | $0.00 |
DisclosureSEC source: 0001186518-26-000008 · form4-05112026_040525.xml · nonDerivative · entry 1 HUNTER GORDON · CIK 0001186518 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,954 F1 · shares: These shares were awarded as restricted stock pursuant to the Veeco Instruments Inc. 2019 Stock Incentive Plan in consideration of services as a director. These shares are subject to certain restrictions which shall lapse on the earlier to occur of: (i) the date immediately preceding the date of the Company's 2027 Annual Meeting of stockholders and (ii) the first anniversary of the award date. Read SEC document |
| May 08, 2026 Filed May 11, 2026 20:30 UTC |
RAYMOND MARY JANEDirector
|
GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001192758-26-000006 · form4-05112026_040529.xml · nonDerivative · entry 2 RAYMOND MARY JANE · CIK 0001192758 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,967 F2 · shares: This transaction involved a gift of securities by the reporting person to St. Joseph's University. Read SEC document |
| May 08, 2026 Filed May 11, 2026 20:30 UTC |
RAYMOND MARY JANEDirector
|
GrantCommon Stock | 2,945 | $0.00 | $0.00 |
DisclosureSEC source: 0001192758-26-000006 · form4-05112026_040529.xml · nonDerivative · entry 1 RAYMOND MARY JANE · CIK 0001192758 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,967 F1 · shares: These shares were awarded as restricted stock pursuant to the Veeco Instruments Inc. 2019 Stock Incentive Plan in consideration of services as a director. These shares are subject to certain restrictions which shall lapse on the earlier to occur of: (i) the date immediately preceding the date of the Company's 2027 Annual Meeting of stockholders and (ii) the first anniversary of the award date. Read SEC document |
| May 07, 2026 Filed May 11, 2026 20:45 UTC |
Miller William JohnDirector · CEO
|
SaleCommon Stock | 100,000 | $59.55 | $5,955,000.00 |
DisclosureSEC source: 0001497582-26-000014 · form4-05112026_040501.xml · nonDerivative · entry 1 Miller William John · CIK 0001497582 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 419,570 F1 · price: Reflects average weighted sale price. Actual sale prices ranged from $59.53 to $61.03 per share. The reporting person undertakes to provide, upon the request of the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 20:35 UTC |
KIERNAN JOHN PSVP & CHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 15,049 | $31.00 | $466,519.00 |
DisclosureSEC source: 0001251708-26-000006 · form4-03242026_040302.xml · nonDerivative · entry 2 KIERNAN JOHN P · CIK 0001251708 · SVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,622 F2 · shares: Represents securities surrendered to Veeco to satisfy tax withholding obligations due upon the vesting of restricted stock. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 20:35 UTC |
KIERNAN JOHN PSVP & CHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 30,274 | $0.00 | $0.00 |
DisclosureSEC source: 0001251708-26-000006 · form4-03242026_040302.xml · nonDerivative · entry 1 KIERNAN JOHN P · CIK 0001251708 · SVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,671 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On March 13, 2023, the reporting person was granted the contingent right to receive 17,550 performance-based restricted stock units ("PRSUs"). This contingent right was subject to the reporting person's continued service with the Company and the achievement of three-year performance criteria, which was based on the Company's total shareholder return relative to other companies in the Russell 2000 as specified in the award agreement (the "Criteria"). Each PRSU represented the contingent right to receive one share of Veeco common stock. The award, if earned, could range from 50% to 200% of the granted PRSUs based on the achievement of the Criteria. The common stock award reflected in this filing represents achievement at the 172.5% level, which was realized. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 20:45 UTC |
Miller William JohnDirector · CEO
|
Tax withholdingCommon Stock | 61,053 | $31.00 | $1,892,643.00 |
DisclosureSEC source: 0001497582-26-000009 · form4-03242026_040302.xml · nonDerivative · entry 2 Miller William John · CIK 0001497582 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 687,570 F2 · shares: Represents securities surrendered to Veeco to satisfy tax withholding obligations due upon the vesting of restricted stock. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 20:45 UTC |
Miller William JohnDirector · CEO
|
Exercise / conversionCommon Stock | 140,157 | $0.00 | $0.00 |
DisclosureSEC source: 0001497582-26-000009 · form4-03242026_040302.xml · nonDerivative · entry 1 Miller William John · CIK 0001497582 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 748,623 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On March 13, 2023, the reporting person was granted the contingent right to receive 81,250 performance-based restricted stock units ("PRSUs"). This contingent right was subject to the reporting person's continued service with the Company and the achievement of three-year performance criteria, which was based on the Company's total shareholder return relative to other companies in the Russell 2000 as specified in the award agreement (the "Criteria"). Each PRSU represented the contingent right to receive one share of Veeco common stock. The award, if earned, could range from 50% to 200% of the granted PRSUs based on the achievement of the Criteria. The common stock award reflected in this filing represents achievement at the 172.5% level, which was realized. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 20:30 UTC |
Devasahayam AdrianSVP - PRODUCT LINE DEVELOPMENT
|
GrantCommon Stock | 373 | $25.96 | $9,682.71 |
DisclosureSEC source: 0001811702-26-000006 · form4-03242026_040301.xml · nonDerivative · entry 3 Devasahayam Adrian · CIK 0001811702 · SVP - PRODUCT LINE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,522.208 F3 · shares: Represents 373 shares purchased under the Veeco Employee Stock Purchase Plan on March 20, 2026. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 20:30 UTC |
Devasahayam AdrianSVP - PRODUCT LINE DEVELOPMENT
|
Tax withholdingCommon Stock | 10,144 | $31.00 | $314,464.00 |
DisclosureSEC source: 0001811702-26-000006 · form4-03242026_040301.xml · nonDerivative · entry 2 Devasahayam Adrian · CIK 0001811702 · SVP - PRODUCT LINE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,149.208 F2 · shares: Represents securities surrendered to Veeco to satisfy tax withholding obligations due upon the vesting of restricted stock. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 20:30 UTC |
Devasahayam AdrianSVP - PRODUCT LINE DEVELOPMENT
|
Exercise / conversionCommon Stock | 26,910 | $0.00 | $0.00 |
DisclosureSEC source: 0001811702-26-000006 · form4-03242026_040301.xml · nonDerivative · entry 1 Devasahayam Adrian · CIK 0001811702 · SVP - PRODUCT LINE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,293.208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On March 13, 2023, the reporting person was granted the contingent right to receive 15,600 performance-based restricted stock units ("PRSUs"). This contingent right was subject to the reporting person's continued service with the Company and the achievement of three-year performance criteria, which was based on the Company's total shareholder return relative to other companies in the Russell 2000 as specified in the award agreement (the "Criteria"). Each PRSU represented the contingent right to receive one share of Veeco common stock. The award, if earned, could range from 50% to 200% of the granted PRSUs based on the achievement of the Criteria. The common stock award reflected in this filing represents achievement at the 172.5% level, which was realized. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 20:25 UTC |
Porshnev PeterChief Technology Officer
|
GrantCommon Stock | 593 | $25.96 | $15,393.69 |
DisclosureSEC source: 0001805363-26-000006 · form4-03242026_040301.xml · nonDerivative · entry 3 Porshnev Peter · CIK 0001805363 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 195,059.306 F3 · shares: Represents 593 shares purchased under the Veeco Employee Stock Purchase Plan on March 20, 2026. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 20:25 UTC |
Porshnev PeterChief Technology Officer
|
Tax withholdingCommon Stock | 11,397 | $31.00 | $353,307.00 |
DisclosureSEC source: 0001805363-26-000006 · form4-03242026_040301.xml · nonDerivative · entry 2 Porshnev Peter · CIK 0001805363 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 194,466.306 F2 · shares: Represents securities surrendered to Veeco to satisfy tax withholding obligations due upon the vesting of restricted stock. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 20:25 UTC |
Porshnev PeterChief Technology Officer
|
Exercise / conversionCommon Stock | 26,910 | $0.00 | $0.00 |
DisclosureSEC source: 0001805363-26-000006 · form4-03242026_040301.xml · nonDerivative · entry 1 Porshnev Peter · CIK 0001805363 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,863.306 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On March 13, 2023, the reporting person was granted the contingent right to receive 15,600 performance-based restricted stock units ("PRSUs"). This contingent right was subject to the reporting person's continued service with the Company and the achievement of three-year performance criteria, which was based on the Company's total shareholder return relative to other companies in the Russell 2000 as specified in the award agreement (the "Criteria"). Each PRSU represented the contingent right to receive one share of Veeco common stock. The award, if earned, could range from 50% to 200% of the granted PRSUs based on the achievement of the Criteria. The common stock award reflected in this filing represents achievement at the 172.5% level, which was realized. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 20:20 UTC |
Wilkerson SusanSVP, GLOBAL SALES & SERVICE
|
GrantCommon Stock | 549 | $25.96 | $14,251.49 |
DisclosureSEC source: 0001809296-26-000006 · form4-03242026_040301.xml · nonDerivative · entry 3 Wilkerson Susan · CIK 0001809296 · SVP, GLOBAL SALES & SERVICE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,696.525 F3 · shares: Represents 549 shares purchased under the Veeco Employee Stock Purchase Plan on March 20, 2026. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 20:20 UTC |
Wilkerson SusanSVP, GLOBAL SALES & SERVICE
|
Tax withholdingCommon Stock | 6,996 | $31.00 | $216,876.00 |
DisclosureSEC source: 0001809296-26-000006 · form4-03242026_040301.xml · nonDerivative · entry 2 Wilkerson Susan · CIK 0001809296 · SVP, GLOBAL SALES & SERVICE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,147.525 F2 · shares: Represents securities surrendered to Veeco to satisfy tax withholding obligations due upon the vesting of restricted stock. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 20:20 UTC |
Wilkerson SusanSVP, GLOBAL SALES & SERVICE
|
Exercise / conversionCommon Stock | 26,910 | $0.00 | $0.00 |
DisclosureSEC source: 0001809296-26-000006 · form4-03242026_040301.xml · nonDerivative · entry 1 Wilkerson Susan · CIK 0001809296 · SVP, GLOBAL SALES & SERVICE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,143.525 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On March 13, 2023, the reporting person was granted the contingent right to receive 15,600 performance-based restricted stock units ("PRSUs"). This contingent right was subject to the reporting person's continued service with the Company and the achievement of three-year performance criteria, which was based on the Company's total shareholder return relative to other companies in the Russell 2000 as specified in the award agreement (the "Criteria"). Each PRSU represented the contingent right to receive one share of Veeco common stock. The award, if earned, could range from 50% to 200% of the granted PRSUs based on the achievement of the Criteria. The common stock award reflected in this filing represents achievement at the 172.5% level, which was realized Read SEC document |
| March 16, 2026 Filed Mar 17, 2026 20:55 UTC |
Devasahayam AdrianSVP - PRODUCT LINE DEVELOPMENT
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,667 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001811702-26-000004 · form4-03172026_040301.xml · derivative · entry 9 Devasahayam Adrian · CIK 0001811702 · SVP - PRODUCT LINE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,667 Underlying: common stock · 2,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.expiration_date: These restricted units (RSUs) were acquired pursuant to an award under the Veeco Instruments 2019 Stock Incentive Plan and are subject to certain restrictions. These restrictions will lapse with respect to 1/3 of such RSUs on each of the first, second and third anniversaries of the date of grant. Vested shares of Veeco common stock will be delivered to the reporting person on the vesting date. Read SEC document |
| March 16, 2026 Filed Mar 17, 2026 20:55 UTC |
Devasahayam AdrianSVP - PRODUCT LINE DEVELOPMENT
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,800 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001811702-26-000004 · form4-03172026_040301.xml · derivative · entry 8 Devasahayam Adrian · CIK 0001811702 · SVP - PRODUCT LINE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,600 Underlying: common stock · 2,800 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.expiration_date: These restricted units (RSUs) were acquired pursuant to an award under the Veeco Instruments 2019 Stock Incentive Plan and are subject to certain restrictions. These restrictions will lapse with respect to 1/3 of such RSUs on each of the first, second and third anniversaries of the date of grant. Vested shares of Veeco common stock will be delivered to the reporting person on the vesting date. Read SEC document |
| March 16, 2026 Filed Mar 17, 2026 20:55 UTC |
Devasahayam AdrianSVP - PRODUCT LINE DEVELOPMENT
|
Tax withholdingCommon Stock | 1,010 | $30.95 | $31,259.50 |
DisclosureSEC source: 0001811702-26-000004 · form4-03172026_040301.xml · nonDerivative · entry 6 Devasahayam Adrian · CIK 0001811702 · SVP - PRODUCT LINE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,383.208 F2 · shares: Represents securities surrendered to Veeco to satisfy tax withholding due upon the vesting of restricted stock. Read SEC document |
| March 16, 2026 Filed Mar 17, 2026 20:55 UTC |
Devasahayam AdrianSVP - PRODUCT LINE DEVELOPMENT
|
Exercise / conversionCommon Stock | 2,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001811702-26-000004 · form4-03172026_040301.xml · nonDerivative · entry 5 Devasahayam Adrian · CIK 0001811702 · SVP - PRODUCT LINE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,393.208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These restricted units (RSUs) were acquired pursuant to an award under the Veeco Instruments 2019 Stock Incentive Plan and are subject to certain restrictions. These restrictions will lapse with respect to 1/3 of such RSUs on each of the first, second and third anniversaries of the date of grant. Vested shares of Veeco common stock will be delivered to the reporting person on the vesting date. Read SEC document |
| March 16, 2026 Filed Mar 17, 2026 20:55 UTC |
Devasahayam AdrianSVP - PRODUCT LINE DEVELOPMENT
|
Tax withholdingCommon Stock | 983 | $30.95 | $30,423.85 |
DisclosureSEC source: 0001811702-26-000004 · form4-03172026_040301.xml · nonDerivative · entry 4 Devasahayam Adrian · CIK 0001811702 · SVP - PRODUCT LINE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,593.208 F2 · shares: Represents securities surrendered to Veeco to satisfy tax withholding due upon the vesting of restricted stock. Read SEC document |
| March 16, 2026 Filed Mar 17, 2026 20:55 UTC |
Devasahayam AdrianSVP - PRODUCT LINE DEVELOPMENT
|
Exercise / conversionCommon Stock | 2,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001811702-26-000004 · form4-03172026_040301.xml · nonDerivative · entry 3 Devasahayam Adrian · CIK 0001811702 · SVP - PRODUCT LINE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,576.208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These restricted units (RSUs) were acquired pursuant to an award under the Veeco Instruments 2019 Stock Incentive Plan and are subject to certain restrictions. These restrictions will lapse with respect to 1/3 of such RSUs on each of the first, second and third anniversaries of the date of grant. Vested shares of Veeco common stock will be delivered to the reporting person on the vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.